The Mouse Core is designed to provide animal breeding, maintenance, and phenotyping resources for program research projects and cores with a focus on the WRN gene, genomic instability and tumorigenesis. This core addresses the animal needs of the program project in a way as to increase the efficiency of animal use. Two common themes are prevalent: 1) the generation and use of genetically altered mice, and 2) the use of whole animal assays to help characterize features of tumor development and other related phenotypes.
Specific aim 1 will generate new ES cell and 'knock-in' mouse models of WRN missense mutations and determine their cellular and organismal phenotypes. This core will provide the transgenic technology, resources and expertise to generate new lines of mice. All of the resources are in place to make targeting vectors, target mouse ES cells, generate chimeras and mutant mice, and genotype offspring to identify permanent founders.
Specific aim 2 will maintain breeding colonies for new and established lines of mice. It is essential that the integrity of the genetic alteration of a specific line be maintained over several generations of back-crossing using sound breeding practices and accurate record keeping. In addition, basic observational assessments will be performed at the colony level to detect any unusual characteristics of newly generated mouse lines.
Specific Aim 3 will conduct longitudinal studies on experimental cohorts of genetically defined mice. Phenotypic changes will be monitored and assessed in mice involved in project experiments. A systematic approach is necessary to detect phenotypic differences not easily discernible by casual observations. This core will provide mouse imaging resources as part of the phenotyping procedure. The need for an animal core is paramount in that all projects use mice. Consolidation of animal resources focused on maximizing efficiency and minimizing costs is essential to the success of this program project.
| Orozco, Javier I J; Knijnenburg, Theo A; Manughian-Peter, Ayla O et al. (2018) Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun 9:4627 |
| Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334 |
| Mikheev, Andrei M; Mikheeva, Svetlana A; Severs, Liza J et al. (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188-1202 |
| Lee, Su-In; Celik, Safiye; Logsdon, Benjamin A et al. (2018) A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 9:42 |
| Salk, Jesse J; Schmitt, Michael W; Loeb, Lawrence A (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet 19:269-285 |
| Davis, Luther; Zhang, Yinbo; Maizels, Nancy (2018) Assaying Repair at DNA Nicks. Methods Enzymol 601:71-89 |
| Yu, Ming; Heinzerling, Tai J; Grady, William M (2018) DNA Methylation Analysis Using Droplet Digital PCR. Methods Mol Biol 1768:363-383 |
| Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6 |
| Poston, Jacqueline N; Becker, Pamela S (2017) Controversies Regarding Use of Myeloid Growth Factors in Leukemia. J Natl Compr Canc Netw 15:1551-1557 |
| Kamath-Loeb, Ashwini S; Zavala-van Rankin, Diego G; Flores-Morales, Jeny et al. (2017) Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype. Sci Rep 7:44081 |
Showing the most recent 10 out of 137 publications
